The Financial Times reports today that BD (NYSE: BDX) began discussions with competitors for the sale of its Life Sciences ...

The effect of saccharin on the microbiome has received much attention, but its impact on pathogenic bacterial species is less ...

today announced the launch of the BD FACSymphony™ S6 cell sorter, which will be on display at the 33rd Congress of the International Society for Advancement of Cytometry next week in Prague. The new ...

“We believe that allogeneic therapies, in particular iPSC-based approaches can deliver the necessary scale to satisfy large patient numbers,” said Victor Aguilar Lopez, senior director, BD ...